vs

Side-by-side financial comparison of BIOHARVEST SCIENCES INC. (BHST) and CHICAGO RIVET & MACHINE CO (CVR). Click either name above to swap in a different company.

BIOHARVEST SCIENCES INC. is the larger business by last-quarter revenue ($8.4M vs $6.0M, roughly 1.4× CHICAGO RIVET & MACHINE CO).

BioHarvest Sciences Inc. is a biotechnology firm that develops and produces sustainable, high-purity plant-derived bioactive ingredients. It serves the nutraceutical, cosmetics, and pharmaceutical sectors, leveraging proprietary cell cultivation technology to create efficacious natural products without large-scale agricultural farming.

Chicago Pneumatic, also known as "CP", is an industrial manufacturer providing power tools, air compressors, generators, light towers and hydraulic equipment. Products are sold in more than 150 countries through a worldwide distribution network. CP is active on markets such as tools for industrial production, vehicle service, maintenance repair operation for mining, construction, infrastructure equipment.

BHST vs CVR — Head-to-Head

Bigger by revenue
BHST
BHST
1.4× larger
BHST
$8.4M
$6.0M
CVR

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BHST
BHST
CVR
CVR
Revenue
$8.4M
$6.0M
Net Profit
$-1.2M
Gross Margin
60.3%
2.7%
Operating Margin
-15.3%
Net Margin
-19.3%
Revenue YoY
45.9%
Net Profit YoY
68.0%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHST
BHST
CVR
CVR
Q4 25
$6.0M
Q3 25
$8.4M
$7.4M
Q2 25
$8.1M
$7.3M
Q1 25
$7.7M
$7.2M
Q4 24
$4.1M
Q3 24
$6.5M
$7.0M
Q2 24
$6.0M
$8.1M
Q1 24
$7.9M
Net Profit
BHST
BHST
CVR
CVR
Q4 25
$-1.2M
Q3 25
$67.6K
Q2 25
$-395.0K
Q1 25
$401.0K
Q4 24
$-3.6M
Q3 24
$-1.4M
Q2 24
$142.1K
Q1 24
$-698.0K
Gross Margin
BHST
BHST
CVR
CVR
Q4 25
2.7%
Q3 25
60.3%
18.1%
Q2 25
60.0%
13.4%
Q1 25
58.2%
22.9%
Q4 24
-43.7%
Q3 24
10.0%
Q2 24
17.6%
Q1 24
9.5%
Operating Margin
BHST
BHST
CVR
CVR
Q4 25
-15.3%
Q3 25
0.9%
Q2 25
-5.7%
Q1 25
1.0%
Q4 24
-86.4%
Q3 24
-11.8%
Q2 24
1.3%
Q1 24
-11.5%
Net Margin
BHST
BHST
CVR
CVR
Q4 25
-19.3%
Q3 25
0.9%
Q2 25
-5.4%
Q1 25
5.5%
Q4 24
-88.0%
Q3 24
-20.8%
Q2 24
1.8%
Q1 24
-8.9%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHST
BHST
CVR
CVR
Cash + ST InvestmentsLiquidity on hand
$1.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$18.8M
Total Assets
$23.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BHST
BHST
CVR
CVR
Q4 25
$1.7M
Q3 25
$1.7M
Q2 25
$1.2M
Q1 25
$765.6K
Q4 24
$2.2M
Q3 24
$2.2M
Q2 24
$2.6M
Q1 24
$2.7M
Total Debt
BHST
BHST
CVR
CVR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BHST
BHST
CVR
CVR
Q4 25
$18.8M
Q3 25
$20.0M
Q2 25
$20.0M
Q1 25
$20.4M
Q4 24
$20.0M
Q3 24
$23.7M
Q2 24
$25.2M
Q1 24
$25.2M
Total Assets
BHST
BHST
CVR
CVR
Q4 25
$23.3M
Q3 25
$24.0M
Q2 25
$23.6M
Q1 25
$24.1M
Q4 24
$23.4M
Q3 24
$26.4M
Q2 24
$27.3M
Q1 24
$27.8M
Debt / Equity
BHST
BHST
CVR
CVR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BHST
BHST
CVR
CVR
Operating Cash FlowLast quarter
$116.4K
Free Cash FlowOCF − Capex
$24.3K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BHST
BHST
CVR
CVR
Q4 25
$116.4K
Q3 25
$638.0K
Q2 25
$28.2K
Q1 25
$-2.0M
Q4 24
$-60.1K
Q3 24
$-58.2K
Q2 24
$363.5K
Q1 24
$-398.8K
Free Cash Flow
BHST
BHST
CVR
CVR
Q4 25
$24.3K
Q3 25
$492.1K
Q2 25
$-22.8K
Q1 25
$-2.1M
Q4 24
$-118.1K
Q3 24
$-368.9K
Q2 24
$58.0K
Q1 24
$-491.8K
FCF Margin
BHST
BHST
CVR
CVR
Q4 25
0.4%
Q3 25
6.7%
Q2 25
-0.3%
Q1 25
-28.3%
Q4 24
-2.9%
Q3 24
-5.3%
Q2 24
0.7%
Q1 24
-6.3%
Capex Intensity
BHST
BHST
CVR
CVR
Q4 25
1.5%
Q3 25
2.0%
Q2 25
0.7%
Q1 25
0.6%
Q4 24
1.4%
Q3 24
4.5%
Q2 24
3.8%
Q1 24
1.2%
Cash Conversion
BHST
BHST
CVR
CVR
Q4 25
Q3 25
9.44×
Q2 25
Q1 25
-5.01×
Q4 24
Q3 24
Q2 24
2.56×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BHST
BHST

Segment breakdown not available.

CVR
CVR

Fastener$5.1M85%
Other$890.7K15%

Related Comparisons